Your browser doesn't support javascript.
loading
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
Bieber, Thomas; Reich, Kristian; Paul, Carle; Tsunemi, Yuichiro; Augustin, Matthias; Lacour, Jean-Philippe; Ghislain, Pierre-Dominique; Dutronc, Yves; Liao, Ran; Yang, Fan E; Brinker, Dennis; DeLozier, Amy M; Meskimen, Eric; Janes, Jonathan M; Eyerich, Kilian.
Afiliación
  • Bieber T; Department of Dermatology and Allergy, University Hospital, Bonn, Germany and Christine Kühne-Center of Allergy Research and Education, Davos, Switzerland.
  • Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Care Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Paul C; Toulouse University and CHU, Toulouse, France.
  • Tsunemi Y; Department of Dermatology, Saitama Medical University, Saitama, Japan.
  • Augustin M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lacour JP; University Hospital of Nice-Côte d'Azur, Nice, France.
  • Ghislain PD; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Dutronc Y; Eli Lilly and Company, Indianapolis, IN, USA.
  • Liao R; Eli Lilly and Company, Indianapolis, IN, USA.
  • Yang FE; Eli Lilly and Company, Indianapolis, IN, USA.
  • Brinker D; Eli Lilly and Company, Indianapolis, IN, USA.
  • DeLozier AM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Meskimen E; Eli Lilly and Company, Indianapolis, IN, USA.
  • Janes JM; Eli Lilly and Company, Indianapolis, IN, USA.
  • Eyerich K; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
Br J Dermatol ; 187(3): 338-352, 2022 09.
Article en En | MEDLINE | ID: mdl-35484697
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_non_migraine_headache / 6_other_respiratory_diseases / 6_skin_diseases / 6_venous_thromboembolic_disease Asunto principal: Nasofaringitis / Dermatitis Atópica / Fármacos Dermatológicos / Gripe Humana / Herpes Simple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 1_doencas_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_non_migraine_headache / 6_other_respiratory_diseases / 6_skin_diseases / 6_venous_thromboembolic_disease Asunto principal: Nasofaringitis / Dermatitis Atópica / Fármacos Dermatológicos / Gripe Humana / Herpes Simple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Br J Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Suiza